Efficacy of intravenous branched chain amino acids in Hepatic Encephalopathy
Not Applicable
Completed
- Conditions
- Health Condition 1: K729- Hepatic failure, unspecified
- Registration Number
- CTRI/2020/04/024520
- Lead Sponsor
- Madhumita Premkumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
Patients with ACLF (CANONIC definition) of any aetiology with HE >= grade 2 as per West-Haven Criteria
Exclusion Criteria
1. Those who do not consent to participate in the study
2. Patients with structural brain lesions or stroke
3. Inability to obtain informed consent from patient or relatives
4. Severe preexisting cardiopulmonary disease
5. Renal dysfunction (S. Creatinine >= 2mg/dL)
6. Pregnancy/Lactation
7.. Post liver transplant patients
8. HIV infection
9. Patients who are on psychoactive drugs, like sedatives or antidepressants
10. Patients who are too sick to carry out the protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method